Skip to content

Harrow HROW EBITDA margin

EBITDA margin at other companies

AbbVie logo
AbbVieABBV
37.3%
Bausch + Lomb logo
Bausch + LombBLCO
12.4%+1.9pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-566.5%+1,247pp
Viatris logo
ViatrisVTRS
20.3%+17.9pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
17%-11.8pp
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-9.2%-4.1pp

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Calculated from Harrow’s reported figures.

Based on trailing twelve months.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's EBITDA margin?
Harrow (HROW) reported EBITDA margin of 8% in Q1 2026.
How has Harrow's EBITDA margin changed year-over-year?
Harrow's EBITDA margin increased by 167.0% year-over-year, from 3% to 8%.
What is the long-term trend for Harrow's EBITDA margin?
Over 5 years (2020 to 2025), Harrow's EBITDA margin has grown at a 20.8% compound annual growth rate (CAGR), from 4.6% to 11.9%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.